What is the US6130072 patent for acarbose?
U.S. Patent 6,130,072 describes a method for preparing acarbose, an oral alpha-glucosidase inhibitor used to treat type 2 diabetes. The patent, filed by Bayer AG, claims a process that involves the microbial fermentation of a specific strain of Actinoplanes utahensis [1].
What does this patent cover specifically?
The patent details a fermentation process to produce acarbose using a microorganism identified as Actinoplanes utahensis strain ATCC 31033 [1]. This strain is cultivated under specific conditions to yield the active pharmaceutical ingredient.
When did this patent expire?
The original expiration date for U.S. Patent 6,130,072 was June 11, 2018 [1].
How does acarbose work to treat diabetes?
Acarbose works by inhibiting alpha-glucosidase enzymes in the small intestine. These enzymes are responsible for breaking down complex carbohydrates into simpler sugars that can be absorbed into the bloodstream. By slowing down carbohydrate digestion, acarbose helps to reduce post-meal blood glucose spikes [2].
Are there other patents related to acarbose?
DrugPatentWatch.com lists multiple patents associated with acarbose, covering various aspects including different manufacturing processes, formulations, and potential new uses. The patent landscape for a drug can be complex, with patents on the active ingredient itself, as well as on how it is made or delivered [3].
What are the alternatives to acarbose for type 2 diabetes?
Other classes of medications are available for managing type 2 diabetes, including metformin, sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors. The choice of medication depends on individual patient needs, comorbidities, and treatment goals [4].
What side effects are associated with acarbose?
Common side effects of acarbose include gastrointestinal issues such as diarrhea, flatulence, and abdominal pain, primarily due to undigested carbohydrates reaching the colon [2].
Sources:
[1] https://drugpatentwatch.com/us6130072
[2] https://www.ncbi.nlm.nih.gov/books/NBK537244/
[3] https://drugpatentwatch.com/acarbose
[4] https://www.niddk.nih.gov/health-information/diabetes/overview-diabetes/type-2-diabetes/medications